Roth Capital analyst Eric Handler raised the firm’s price target on Imax (IMAX) to $42 from $40 and keeps a Buy rating on the shares following the investor day. The company announced “bullish” near- and long-term targets which topped consensus estimates, the analyst tells investors in a research note. The firm believes Imax is well positioned for a “strong, multi-year growth cycle” given its expanding box office market share. TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insi ...